Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy

Fujian Medical University

Status: Active, not recruiting

Conditions: Surgery, Laparoscopic; Gastric Adenocarcinoma

Treatments: Other: None-placebo

Study type: Observational

Funder types: Other

Identifiers

NCT06938139

Benchmark-MISGC

Details and patient eligibility

About

The Benchmark-MISGC study was a large-scale retrospective observational study launched by the China Gastric Cancer Surgical Union, aiming to establish the benchmarks of the short- and long-term outcomes for gastric cancer patients who underwent minimal invasive gastrectomy.

Enrollment: 90,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with postoperative histologically confirmed gastric adenocarcinoma at stages T1-4a, N0/+, M0;
2. underwent robotic or laparoscopic gastrectomies with curative intent

Exclusion criteria

1. ASA class > 3;
2. remnant gastric cancer;
3. concurrent/previous malignant disease;
4. Distant metastasis;
5. Palliative resection;
6. Abodominal exploration.